Annexin V can be used to detect apoptotic cells in vitro and in vivo, based on its ability to identify extracellular phosphatidylserine, which arises during apoptosis. In the present study, we examined the synthesis of fluorine-18 labelled annexin V as a positron emission tomography tracer for apoptosis imaging. The distribution of [18F]annexin V and technetium-99m labelled annexin V, a well-characterised SPET tracer for apoptosis imaging, was compared. [18F]annexin V was synthesised using N-succinimidyl 4-[18F]fluorobenzoate as an 18F labelling reagent. Synthesised and purified [18F]annexin V was confirmed by SDS-PAGE. In an ex vivo imaging experiment, [18F]annexin V was intravenously injected into rats 24 h after the induction of myocardial ischaemia, and accumulation in the left ventricle was examined. [18F]annexin V accumulated in the infarct area of the left ventricle, where apoptotic cells were observed. In separate experiments, [18F]annexin V or [(99m)Tc]annexin V was intravenously injected into ischaemic or normal animals, and the distribution of the tracers was compared. In ischaemic animals, accumulation of [18F]annexin V and [(99m)Tc]annexin V in the infarct area was about threefold higher than in the non-infarct area. Furthermore, the ratio of accumulation in the normal heart to the blood radioactivity was not significantly different between the tracers. In normal animals, however, the uptake of [18F]annexin V in the liver, spleen and kidney was much lower than that of [(99m)Tc]annexin V. The low uptake of [18F]annexin V in these organs might represent an advantage over [(99m)Tc]annexin V.

No abstract

No abstract

Several kinds of middle cerebral artery occlusion model in rats have been developed. Variable ischemic inductions are attributed to the different contributing factors in ischemic damage formation. In the present study, we examined the differences in ischemic induction attributed to chronic stage. Male Sprague-Dawley rats were subjected to two kinds of middle cerebral artery occlusion model, a thermocoagulation and a photothrombosis model. We compared the changes in body weight, neurological outcome, size of ischemic damage, brain edema and atrophy formation, and histological data for 84 days between a thermocoagulation and a photothrombosis model in rats. Although the time courses of infarction formation were no different, there were differences in the time courses of brain edema, atrophy formation, and neuronal deficits between the models. Microinfarction formation was observed as a characteristic of the photothrombosis model. The present study demonstrated that differences in ischemic induction did not affect maturation of infarct size, brain atrophy, or neuronal deficits 84 days after ischemia. However, the progress of maturation was different between the models. The possibility that reperfusion contributed to the time course of brain edema and atrophy was considered, and it was suggested that brain edema formation influenced neurological outcome.

No abstract